| Identification | Back Directory | [Name]
5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE | [CAS]
27406-31-1 | [Synonyms]
MHY-1685
IFLAB-BB F1208-0006
5-(4-HYDROXYBENZYLIDENE)BARBITURIC ACID
5-(4-HYDROXYBENZYLIDENE)BARBUTIRIC ACID
5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE
5-(4-HYDROXYBENZYLIDENE)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(4-hydroxyphenyl)methylene]- | [Molecular Formula]
C11H8N2O4 | [MDL Number]
MFCD00117979 | [MOL File]
27406-31-1.mol | [Molecular Weight]
232.19 |
| Hazard Information | Back Directory | [Uses]
MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. | [Biological Activity]
MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. | [storage]
Store at -20°C | [References]
[1]. Park JH, et al. Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair. Exp Mol Med. 2021 Sep;53(9):1423-1436. |
|
|